Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001517026-24-000006
Filing Date
2024-10-10
Accepted
2024-10-10 16:36:13
Documents
1
Period of Report
2024-10-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1728592566.html 4  
1 FORM 4 wk-form4_1728592566.xml 4 5207
  Complete submission text file 0001517026-24-000006.txt   6619
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SATL LAKE CITY UT 84116
Business Address
Verratti Mark (Reporting) CIK: 0001517026 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 241365600